• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tela Bio Inc (NQ: TELA )

    2.900 +0.090 (+3.20%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Tela Bio Inc

    < Previous 1 2 Next >
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce Third Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce Second Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Appoints Jeffrey Blizard to its Board of Directors
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Appoints Greg Firestone as Chief Commercial Officer
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Reports First Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce First Quarter 2024 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
    Targets the more than 665,000 inguinal hernia procedures performed annually in the United States (U.S.) 
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
    Howard N. Langstein, MD, FACS joins innovative MedTech company to leverage his vast experience to help other surgeons optimize clinical outcomes in plastic and reconstructive surgery 
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
    Strong and secure, LIQUIFIX is the first approved adhesive-based product to affix mesh without penetrating patient tissue 
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
    TELA Bio to receive at least $8 million and up to $12 million in total consideration 
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Take Part in Connecting the Dots
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Reports Third Quarter 2023 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Announce Third Quarter 2023 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
    New addition expands reconstruction options for surgeons and patients 
    From TELA Bio, Inc.
    Via GlobeNewswire
    TELA Bio Reports Second Quarter 2023 Financial Results
    From TELA Bio, Inc.
    Via GlobeNewswire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.